ArticleMetabolic brain disease2022

Protective effects of isofraxidin against scopolamine-induced cognitive and memory impairments in mice involve modulation of the BDNF-CREB-ERK signaling pathway.

Bingliang Lian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.